CN104313077A - Biological method for producing isoxazolyl ethanol - Google Patents
Biological method for producing isoxazolyl ethanol Download PDFInfo
- Publication number
- CN104313077A CN104313077A CN201410594937.6A CN201410594937A CN104313077A CN 104313077 A CN104313077 A CN 104313077A CN 201410594937 A CN201410594937 A CN 201410594937A CN 104313077 A CN104313077 A CN 104313077A
- Authority
- CN
- China
- Prior art keywords
- substrate
- isoxazole
- bromotrifluoromethane
- reaction
- ramie
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OJSDNYAMXINJQD-UHFFFAOYSA-N 1-(1,2-oxazol-3-yl)ethanol Chemical compound CC(O)C=1C=CON=1 OJSDNYAMXINJQD-UHFFFAOYSA-N 0.000 title abstract 2
- 238000010170 biological method Methods 0.000 title abstract 2
- 240000008564 Boehmeria nivea Species 0.000 claims abstract description 60
- 239000000758 substrate Substances 0.000 claims abstract description 57
- 238000006243 chemical reaction Methods 0.000 claims abstract description 43
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 20
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 claims description 38
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 36
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims description 33
- 239000000243 solution Substances 0.000 claims description 16
- 230000002210 biocatalytic effect Effects 0.000 claims description 12
- 238000009423 ventilation Methods 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- 239000008103 glucose Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 240000008042 Zea mays Species 0.000 claims description 7
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 7
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 7
- 208000012839 conversion disease Diseases 0.000 claims description 7
- 235000005822 corn Nutrition 0.000 claims description 7
- 229960003487 xylose Drugs 0.000 claims description 7
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 6
- 238000003810 ethyl acetate extraction Methods 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 239000002953 phosphate buffered saline Substances 0.000 claims description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 6
- 229920000053 polysorbate 80 Polymers 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000006555 catalytic reaction Methods 0.000 abstract description 10
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000008055 phosphate buffer solution Substances 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 239000005515 coenzyme Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000012847 fine chemical Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000024287 Areas Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 101710157860 Oxydoreductase Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- CJAIZOLZBMJUNG-UHFFFAOYSA-N ethanol;1,2-oxazole Chemical compound CCO.C=1C=NOC=1 CJAIZOLZBMJUNG-UHFFFAOYSA-N 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
The invention discloses a biological method for producing isoxazolyl ethanol. The method comprises the steps of carrying out biological catalysis by using melanomyces cells to prepare photoactive (S)-1-(3-(5-bromomethylisoxazolyl)ethanol; adding a phosphate buffer solution into a reaction tank; and adding ramie gauze to control the concentrations of a substrate and a product. The melanomyces cells are used for biological catalytic reaction, so that the yield of the product is high, the enantiomeric excess rate (ee%) is high, and the method has a favorable application prospect.
Description
Technical field
The invention belongs to technology of pharmaceutical engineering field, be related specifically to the technology that melanomyces cell biocatalysis prepares chiral medicinal intermediate (S)-1-(3-(5-bromotrifluoromethane isoxazole)) ethanol.
Background technology
Chirality (S)-1-(3-(5-bromotrifluoromethane isoxazole)) ethanol is the important intermediate of synthesis of chiral medicine, fine chemicals, agricultural chemicals product and other exotic materialss.Biocatalysis asymmetric reaction has environmental friendliness, mild condition, selectivity advantages of higher, prepares the first approach of hydroxyl chipal compounds as green high-efficient, is applied to the chipal compounds producing some high added values more and more.Biocatalysis is prepared chirality (S)-1-(3-(5-bromotrifluoromethane isoxazole)) ethanol and is had good application prospect.
Biocatalysis has the outstanding advantages such as catalytic efficiency is high, selectivity strong, mild condition, environmental friendliness, is the important method substituting and expand traditional organic chemical synthesis in process of sustainable development.Wherein chiral separation and asymmetric synthesis are the Application Areass of biocatalysis most magnetism.As in six large fermentoids of biological catalyst, lytic enzyme catalytic kinetics resolution of racemates can obtain quiral products, in industrial biocatalytic, play key player always.In recent years, oxydo-reductase application industrially obtained and increased rapidly.At present, the ratio adopting the industry of lytic enzyme Kinetic Resolution, biological catalysis and biological oxidation process to prepare optical activity chirality compound is 4:2:1.Biomass cells reduction method is for Kinetic Resolution, and maximum advantage is that theoretical yield can reach 100%, and Atom economy is good.But bioreduction needs the participation of coenzyme or cofactor, limit its application to a certain extent.Due to the dependent cause of coenzyme, in bioreduction, many Bian intact cells are as catalyzer, realize the purification procedures eliminating enzyme in body while coenzyme cyclic regeneration.
(S)-1-(3-(5-bromotrifluoromethane isoxazole)) ethanol is the important chiral building block of synthesis of chiral medicine, fine chemicals, agricultural chemicals product, and owing to there being 2 chiral centres, make chemosynthesis comparatively difficult, cost is high.The present invention will adopt biocatalysis to prepare (S)-1-(3-(5-bromotrifluoromethane isoxazole)) ethanol.
Summary of the invention
The present invention adopts melanomyces cell catalysis to prepare (S)-1-(3-(5-bromotrifluoromethane isoxazole)) ethanol, and reaction formula is as follows:
Substrate 1-(3-(5-bromotrifluoromethane isoxazole)) ethyl ketone (1), through melanomyces catalyzed reaction, obtains product (S)-1-(3-(5-bromotrifluoromethane isoxazole)) ethanol (2).Have multiple-microorganism can catalysis this reaction, through great many of experiments screening, finally determine adopt melanomyces as catalyzer because its catalysis 1 reaction effect best, reaction yield, enantiomeric excess rate (ee%) are all very high.
Many melanomyces can carry out this reaction of biocatalysis, but its effect is different, differs greatly, and through experiment, the present invention selects melanomyces bacterial strain to be ATCC MYA-1180, and its this reaction effect of catalysis is best.
developing medium:
1, nutrient solution composition: corn steep liquor (with dry basis) content is 35-45g/L; analysis for soybean powder 3-5g/L; yeast extract 6-9g/L, glucose 18-22 g/L, malt extract 25-30 g; ammonium sulfate 0.5-0.7g/L; magnesium sulfate 0.3-0.4g/L, phosphoric acid dioxy potassium 1.8-2.3g/L, calcium carbonate 0.7 g/L; ferrous sulfate 0.18 g/L, manganous sulfate 0.025 g/L; PH 5.3.
2, solid medium composition: the agar powder adding 1.5-2% in liquid medium within.
Prepared by melanomyces wet cell.Melanomyces through inclined-plane, shaking flask, seed tank culture obtain seed liquor; Fermentor tank adds nutrient solution, and coefficient is 0.6-0.7, and 121 DEG C of autoclavings 30 minutes, are cooled to 28-29 DEG C, by melanomyces
aTCC MYA-1180seed liquor is seeded to fermentor tank, and inoculative proportion is 10-15%, and ventilation ratio is 0.5-1V/(V minute), namely per minute air flow is 0.5-1 times of fermentating liquid volume, cultivate 36-40 hour, obtain wet melanomyces cell, as biocatalytic reaction catalyzer with filtering centrifuge is centrifugal for 28-29 DEG C.Wet cell preparation technique is mature technology.
Because substrate, product all have restraining effect to melanomyces cell, in order to reduce the suppression of substrate, products upon cell, the present invention adopts ramie gauze immunoabsorbent substrate, in reaction, when substrate is reacted by cell catalysis, when concentration reduces, substrate from the stripping of ramie gauze, postreaction consume substrate.Meanwhile, product is adsorbed by ramie gauze, decreases its concentration in water, thus considerably reduces the suppression of substrate, products upon cell.The ratio of substrate and ramie gauze, determines the concentration of substrate in reaction solution, product, and concentration is also relevant with temperature of reaction, reaction solution composition.Different cell is different to the susceptibility of substrate, product, so, great many of experiments be carried out, best substrate and the ratio of ramie gauze could be determined.Experiment shows, for bacterial strain of the present invention, reaction solution composition, temperature of reaction, best substrate and the ratio of ramie gauze are 0.26-0.28.During concrete absorption, substrate 1-(3-(5-bromotrifluoromethane isoxazole)) the ethyl ketone ramie gauze being of a size of 0.5cmX0.5cm is absorbed, namely obtains the ramie gauze having adsorbed substrate.Regulate substrate and ramie gauze consumption, make the quality ratio of substrate and ramie gauze be 0.26-0.28.Ramie gauze used is common ramie gauze, and commercially, be cut into 0.5cmX0.5cm fritter, sterilizing, Preservation in sterile condition is stand-by.
Phosphate buffered saline buffer is added in bottom ventilation stirred tank, pH is 4.8, add the ramie gauze having adsorbed substrate 1-(3-(5-bromotrifluoromethane isoxazole)) ethyl ketone, substrate 1-(3-(5-bromotrifluoromethane isoxazole)) ethyl ketone addition is made to be 80-90 g/L, corn steep liquor (with dry basis) content is 16-18g/L, glucose content is 11-13g/L, wood sugar 8-10 g/L, tween 80 content is 11-13g/L, 121 DEG C of autoclavings 30 minutes; When being cooled to 27-28 DEG C, add wet melanomyces cell and make concentration be 26-29g/L, ventilation ratio is 0.11-0.13V/(V minute), namely per minute air flow is 0.11-0.13 times of reaction solution volume, carries out biocatalytic reaction, and the reaction times is 56-60 hour; After reaction terminates, leach cell, ramie gauze respectively, be extracted with ethyl acetate reaction solution, extraction ramie gauze, combined ethyl acetate extraction liquid, steam ethyl acetate, obtain product (S)-1-(3-(5-bromotrifluoromethane isoxazole)) ethanol, reaction conversion ratio 96-98%, product yield 94-96%, enantiomeric excess rate (ee%) 98-99%.
The present invention carries out the work and comprises bacterial strain selection (selecting from more or less a hundred bacterial strain), catalytic reaction condition optimizes (temperature of reaction, air flow, pH), reaction medium is selected and concentration optimization (concentration of substrate, glucose content, Xylose Content, kinds of surfactants (more than 20, kind selects 1) and concentration, other multiple components is selected to get rid of), solid absorption is adopted to control substrate product concentration, thus the suppression reduced cell, test carclazyte, diatomite, cotton gauze, ramie gauze, the many kinds of solids materials such as macropore resin, also once carried out the test of water-organic solvent 2 phase system.Because tested number is very large, although have employed response surface optimization design experiment, drastically reduce the area tested number, tested number is still very large, and total Test carries out just completing more than 2 years, reaches current technical scheme.For photolytic activity product, as reaction conversion ratio 96-98%, during product yield 94-96%, enantiomeric excess rate (ee%), still up to 98-99%, is very not easily, and our work achieves marked improvement.
embodiment 1
Wet melanomyces is produced by ordinary method
aTCC MYA-1180cell, as biocatalytic reaction catalyzer.
The ramie yarn cloth making method of having adsorbed substrate is, substrate 1-(3-(5-bromotrifluoromethane isoxazole)) the ethyl ketone ramie gauze being of a size of 0.5cmX0.5cm is absorbed, namely the ramie gauze having adsorbed substrate is obtained, regulate substrate and ramie gauze consumption, make the quality ratio of substrate and ramie gauze be 0.26.Ramie gauze used is common ramie gauze, and commercially, be cut into 0.5cmX0.5cm fritter, sterilizing, Preservation in sterile condition is stand-by, and other embodiment ramie gauze process is identical.
Phosphate buffered saline buffer is added in 15L bottom ventilation stirred tank, pH is 4.8, add the ramie gauze having adsorbed substrate 1-(3-(5-bromotrifluoromethane isoxazole)) ethyl ketone, substrate 1-(3-(5-bromotrifluoromethane isoxazole)) ethyl ketone addition is made to be 80g/L, corn steep liquor (with dry basis) content is 16g/L, and glucose content is 11g/L, wood sugar 8 g/L, tween 80 content is 11g/L, 121 DEG C of autoclavings 30 minutes; When being cooled to 27 DEG C, add wet melanomyces cell and make concentration be 26g/L, ventilation ratio is 0.11V/(V minute), namely per minute air flow is 0.11 times of reaction solution volume, carries out biocatalytic reaction, and the reaction times is 56 hours; After reaction terminates, leach cell, ramie gauze respectively, be extracted with ethyl acetate reaction solution, extraction ramie gauze, combined ethyl acetate extraction liquid, steam ethyl acetate, obtain product (S)-1-(3-(5-bromotrifluoromethane isoxazole)) ethanol, reaction conversion ratio 96%, product yield 94%, enantiomeric excess rate (ee%) 99%.
embodiment 2
Wet melanomyces is produced by ordinary method
aTCC MYA-1180cell, as biocatalytic reaction catalyzer.
The ramie yarn cloth making method of having adsorbed substrate is, substrate 1-(3-(5-bromotrifluoromethane isoxazole)) the ethyl ketone ramie gauze being of a size of 0.5cmX0.5cm is absorbed, namely the ramie gauze having adsorbed substrate is obtained, regulate substrate and ramie gauze consumption, make the quality ratio of substrate and ramie gauze be 0.28.
Phosphate buffered saline buffer is added in 100L bottom ventilation stirred tank, pH is 4.8, add the ramie gauze having adsorbed substrate 1-(3-(5-bromotrifluoromethane isoxazole)) ethyl ketone, substrate 1-(3-(5-bromotrifluoromethane isoxazole)) ethyl ketone addition is made to be 80-90 g/L, corn steep liquor (with dry basis) content is 18g/L, and glucose content is 13g/L, wood sugar 10 g/L, tween 80 content is 13g/L, 121 DEG C of autoclavings 30 minutes; When being cooled to 28 DEG C, add wet melanomyces cell and make concentration be 29g/L, ventilation ratio is 0.13V/(V minute), namely per minute air flow is 0.13 times of reaction solution volume, carries out biocatalytic reaction, and the reaction times is 60 hours; After reaction terminates, leach cell, ramie gauze respectively, be extracted with ethyl acetate reaction solution, extraction ramie gauze, combined ethyl acetate extraction liquid, steam ethyl acetate, obtain product (S)-1-(3-(5-bromotrifluoromethane isoxazole)) ethanol, reaction conversion ratio 98%, product yield 96%, enantiomeric excess rate (ee%) 98%.
embodiment 3
Wet melanomyces is produced by ordinary method
aTCC MYA-1180cell, as biocatalytic reaction catalyzer.
The ramie yarn cloth making method of having adsorbed substrate is, substrate 1-(3-(5-bromotrifluoromethane isoxazole)) the ethyl ketone ramie gauze being of a size of 0.5cmX0.5cm is absorbed, namely the ramie gauze having adsorbed substrate is obtained, regulate substrate and ramie gauze consumption, make the quality ratio of substrate and ramie gauze be 0.27.
Phosphate buffered saline buffer is added in 500L bottom ventilation stirred tank, pH is 4.8, add the ramie gauze having adsorbed substrate 1-(3-(5-bromotrifluoromethane isoxazole)) ethyl ketone, substrate 1-(3-(5-bromotrifluoromethane isoxazole)) ethyl ketone addition is made to be 85 g/L, corn steep liquor (with dry basis) content is 17g/L, and glucose content is 12g/L, wood sugar 8-10 g/L, tween 80 content is 12g/L, 121 DEG C of autoclavings 30 minutes; When being cooled to 27.5 DEG C, add wet melanomyces cell and make concentration be 28g/L, ventilation ratio is 0.12V/(V minute), namely per minute air flow is 0.12 times of reaction solution volume, carries out biocatalytic reaction, and the reaction times is 58 hours; After reaction terminates, leach cell, ramie gauze respectively, be extracted with ethyl acetate reaction solution, extraction ramie gauze, combined ethyl acetate extraction liquid, steam ethyl acetate, obtain product (S)-1-(3-(5-bromotrifluoromethane isoxazole)) ethanol, reaction conversion ratio 97.2%, product yield 95.3%, enantiomeric excess rate (ee%) 98.6%.
embodiment 4
Wet melanomyces is produced by ordinary method
aTCC MYA-1180cell, as biocatalytic reaction catalyzer.
The ramie yarn cloth making method of having adsorbed substrate is, substrate 1-(3-(5-bromotrifluoromethane isoxazole)) the ethyl ketone ramie gauze being of a size of 0.5cmX0.5cm is absorbed, namely the ramie gauze having adsorbed substrate is obtained, regulate substrate and ramie gauze consumption, make the quality ratio of substrate and ramie gauze be 0.27.
Phosphate buffered saline buffer is added in 1000L bottom ventilation stirred tank, pH is 4.8, add the ramie gauze having adsorbed substrate 1-(3-(5-bromotrifluoromethane isoxazole)) ethyl ketone, substrate 1-(3-(5-bromotrifluoromethane isoxazole)) ethyl ketone addition is made to be 89 g/L, corn steep liquor (with dry basis) content is 17.5g/L, and glucose content is 13g/L, wood sugar 10 g/L, tween 80 content is 12g/L, 121 DEG C of autoclavings 30 minutes; When being cooled to 27.5 DEG C, add wet melanomyces cell and make concentration be 26-29g/L, ventilation ratio is 0.125V/(V minute), namely per minute air flow is 0.125 times of reaction solution volume, carries out biocatalytic reaction, and the reaction times is 59 hours; After reaction terminates, leach cell, ramie gauze respectively, be extracted with ethyl acetate reaction solution, extraction ramie gauze, combined ethyl acetate extraction liquid, steam ethyl acetate, obtain product (S)-1-(3-(5-bromotrifluoromethane isoxazole)) ethanol, reaction conversion ratio 97.6%, product yield 95.8%, enantiomeric excess rate (ee%) 98.7%.
Claims (2)
1. the method for melanomyces cell biocatalysis preparation (S)-1-(3-(5-bromotrifluoromethane isoxazole)) ethanol, it is characterized in that adding phosphate buffered saline buffer in retort, pH is 4.8, add the ramie gauze having adsorbed substrate 1-(3-(5-bromotrifluoromethane isoxazole)) ethyl ketone, substrate 1-(3-(5-bromotrifluoromethane isoxazole)) ethyl ketone addition is made to be 80-90 g/L, corn steep liquor (with dry basis) content is 16-18g/L, glucose content is 11-13g/L, wood sugar 8-10 g/L, tween 80 content is 11-13g/L, 121 DEG C of autoclavings 30 minutes, when being cooled to 27-28 DEG C, add wet melanomyces cell and make concentration be 26-29g/L, ventilation ratio is 0.11-0.13V/(V minute), carry out biocatalytic reaction, the reaction times is 56-60 hour, after reaction terminates, leach cell, ramie gauze respectively, be extracted with ethyl acetate reaction solution, extraction ramie gauze, combined ethyl acetate extraction liquid, steam ethyl acetate, obtain product (S)-1-(3-(5-bromotrifluoromethane isoxazole)) ethanol, reaction conversion ratio 96-98%, product yield 94-96%, enantiomeric excess rate (ee%) 98-99%.
2. method according to claim 1, it is characterized in that described ramie yarn cloth making method of having adsorbed substrate is, substrate 1-(3-(5-bromotrifluoromethane isoxazole)) the ethyl ketone ramie gauze being of a size of 0.5cmX0.5cm is absorbed, namely the ramie gauze having adsorbed substrate is obtained, regulate substrate and ramie gauze consumption, make the quality ratio of substrate and ramie gauze be 0.26-0.28.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410594937.6A CN104313077A (en) | 2014-10-30 | 2014-10-30 | Biological method for producing isoxazolyl ethanol |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410594937.6A CN104313077A (en) | 2014-10-30 | 2014-10-30 | Biological method for producing isoxazolyl ethanol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104313077A true CN104313077A (en) | 2015-01-28 |
Family
ID=52368387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410594937.6A Pending CN104313077A (en) | 2014-10-30 | 2014-10-30 | Biological method for producing isoxazolyl ethanol |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104313077A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1793355A (en) * | 2005-12-01 | 2006-06-28 | 华东理工大学 | Organic solvent slow-releasing system and its preparation and application for catalyzing reaction of enzyme thereof |
-
2014
- 2014-10-30 CN CN201410594937.6A patent/CN104313077A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1793355A (en) * | 2005-12-01 | 2006-06-28 | 华东理工大学 | Organic solvent slow-releasing system and its preparation and application for catalyzing reaction of enzyme thereof |
Non-Patent Citations (3)
| Title |
|---|
| KEN-ICHI ITOH ET AL.: "Biocatalytic asymmetric reduction of 3-acetylisoxazoles", 《TETRAHEDRON:ASYMMETRY》 * |
| MOHAN PAL ET AL.: "Bioreduction of methyl heteroaryl and aryl heteroaryl ketones in high enantiomeric excess with newly isolated fungal strains", 《BIORESOURCE TECHNOLOGY》 * |
| 杨忠华等: "活性酵母细胞不对称催化苯乙酮还原及树脂吸附对反应的促进作用", 《催化学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104293851A (en) | Method for producing hydroxyethyl pyridine by alternaria alternata | |
| CN104342464A (en) | Method for producing chiral phenyl methanol employing catalysis of tarlaromyces flavus | |
| CN104313074A (en) | Method for producing pyridylethanol through penicillium catalysis | |
| CN104263776A (en) | Method for producing chiral pyridine ethanol through biological catalysis | |
| CN104313077A (en) | Biological method for producing isoxazolyl ethanol | |
| CN104313076A (en) | Method for producing methylpyridinyl ethanol through biological catalysis | |
| CN104313062A (en) | Method for producing photoactive phenylethanol through cell catalysis | |
| CN104263775A (en) | Method for producing 4-pyridineethanol by black mould through catalysis | |
| CN104313078A (en) | Method for producing chiral thiazolyl ethanol through biological catalysis | |
| CN104328151A (en) | Method for producing benzothiophene ethanol by using cells as catalyst | |
| CN104313075A (en) | Cell production method for photoactive bromopyridyl ethanol | |
| CN104293852A (en) | Method for producing isoquinoline methyl alcohol through cell catalysis | |
| CN104212843A (en) | Method of reduction production of bromine phenyl propionic acid methyl ester through brewing yeast | |
| CN104293856A (en) | Method for producing fluoropyridine ethanone through cell catalysis | |
| CN104388490A (en) | Method for producing chiral pyrazinyl ethanol by biological catalysis | |
| CN104328154A (en) | Method for producing (S)-phenyl methanol from blue mold | |
| CN104328147A (en) | Production method of chlorine-contaning (2R,3S) methyl methylpropionate | |
| CN104357504A (en) | Cell catalysis for producing chirality methoxyl pyridine ethanol | |
| CN104263774A (en) | Method for catalytic production of chiral cyclohexylidene enol with saccharomyces cerevisiae | |
| CN104263773A (en) | Biological method for producing dioxy-heptenal | |
| CN105039449A (en) | Method for producing (S)-furan ethanol with penicillium | |
| CN104263769A (en) | Method of producing chlorphenyl methyl propionate by biological process | |
| CN105132471A (en) | Method for producing photo-active chloro-benzene chloroethanol by virtue of microorganisms | |
| CN105087698A (en) | Method for producing (S)-1-(4-nitrobenzene)ethanol by utilizing microorganism | |
| CN105039446A (en) | Method for producing (S)-cyanobenzene alcohol through cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150128 |